Customer Reviews
Be the First to write a Review!
alarm Free 2 Day Shipping over $49
Questions? 1 (844) 844 0031
click subdirectory_arrow_left
10
%
OFF
On Your
1st Order
25
%
OFF
On Your
1st Order
25
%
OFF
On Your
1st Order
10
$
OFF
On Your
1st Order
35
%
OFF
On Your 1st
Autoship
Click to open
expanded view

Prascend

Dopamine agonist tablet for the treatment of PPID

Species: Horse
Prescription required
Strength:
Count:
FREE shipping over $49
Ships Free!
cached
Autoship available
during checkout

Prascend

Dopamine agonist tablet for the treatment of PPID

Species: Horse
Prescription required
Strength:
Count:
FREE shipping over $49
Ships Free!
cached
Autoship available
during checkout
Product images:

Product description

Pituitary pars intermedia dysfunction (PPID), also referred to as equine Cushing’s disease, is one of the most common endocrine disorders in horses. PPID originates from a degeneration of the hypothalamic dopamine-producing neurons. The lack of sufficient dopamine causes the horse's pituitary gland, which utilizes hormones to control body functions, to work overtime. This can lead to a variety of problems for horses, ranging from delayed shedding to loss of muscle mass.

Some Clinical Signs of PPID
  • Loss of seasonal hair coat shedding
  • Decreased performance
  • Change in attitudes
  • Recurrent infections
  • Abnormal sweating
  • Laminitis

When it comes to treating PPID in horses, the earlier the better. Using Prascend as part of PPID management protocol can help reduce the clinical signs of PPID to improve the quality of life of your horse. Prascend is a dopamine agonist, it acts to replace the dopamine that is missing from the intermediate lobe of the pituitary gland in horses with PPID. By binding to the dopamine receptor, Prascend decreases the production of hormones by the intermediate lobe.

Prascend tablets are rectangular, light-red, half-scored tablets containing 1 mg pergolide, as pergolide mesylate, a dopamine receptor agonist for oral use in horses only.

Active ingredients

1 mg of pergolide mesylate.

Indications for use

Prascend tablets are indicated for the control of clinical signs associated with Pituitary Pars Intermedia Dysfunction (Equine Cushing’s Disease) in horses.

Administration and dosage

Preserved and protected in foil blister packs, the single-scored tablets make it simple to adjust dosage. Administer orally at a starting dose of 2 mcg/kg once daily. Dosage may be adjusted to effect, not to exceed 4 mcg/kg daily. Prascend tablets should not be crushed due to the potential for increased human exposure and care should be taken to minimize exposure when splitting tablets.

Body Weight Dosage 2 mcg/kg Dosage 4 mcg/kg
300 - 749 lbs 0.5 tablet 1 tablet
750 – 1,249 lbs  1 tablet 2 tablets
1,250 – 1,749 lbs  1.5 tablets 3 tablets
1,750 – 2,249 lbs 2 tablets 4 tablets

Prescribing information

picture_as_pdf Prascend
Manufactured by Boehringer Ingelheim. Shop all Prascend products